This 2021 systematic review and meta-analysis, published in Journal of Gastroenterology and Hepatology, evaluated the efficacy of vitamin E supplementation in adults with non-alcoholic fatty liver disease (NAFLD). The analysis included eight randomized controlled trials encompassing 669 participants. Results demonstrated that vitamin E supplementation significantly reduced serum alanine aminotransferase (ALT)
